Nice to see we are back again. Good be really good MT-LT investment and can follow same path as RAP & MDR.
Cost effective Pain assessment tool - A point of care App which utilises facial recognition technology to detect micro- expressions which are indicative of presence of pain.
ePAT App is designed to allow pain assessments to be: § Simple § Accurate § Objective § Reproducible
Opportunistic markets where there is a current need for ePAT technology, examples include: § Tele-Health Ø Support clinician remote patient assessments § Insurance Claims Ø Assisting in assessment of personal injury claims § Pharmaceutical Companies Ø Monitoring tool for clinical trials of pain relief drugs.
ePAT vs Abbey Pain Scale
Patients n = 40
Assessments = 354
Correlation coefficient = 0.90
Fund is raised for near 2 years est budget and NO CR expected anytime soon.
[email protected] were issued to raise $4.5M
Out of 657m ; 213m (34%) are escrowed for 2 years
Taking its time but this could proven to be another RAP. Patience is the key for MT-LT.
- Forums
- ASX - By Stock
- Ann: Presentation to Extraordinary General Meeting-MNQ.AX
Nice to see we are back again. Good be really good MT-LT...
-
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MNQ (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
Previous Video
Next Video
SPONSORED BY The Market Online